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Abstract
Leucine-rich repeat kinase 2 (LRRK2) is a multi-domain 280 kDa protein that is linked to Parkinson’s disease (PD). Mutations
especially in the GTPase and kinase domains of LRRK2 are the most common causes of heritable PD and are also found in
sporadic forms of PD. Although the cellular function of LRRK2 is largely unknown there is increasing evidence that these
mutations cause cell death due to autophagic dysfunction and mitochondrial damage. Here, we demonstrate a novel
mechanism of LRRK2 binding and transport, which involves the small GTPases Rab32 and Rab38. Rab32 and its closest
homologue Rab38 are known to organize the trans-Golgi network and transport of key enzymes in melanogenesis, whereas
their function in non-melanogenic cells is still not well understood. Cellular processes such as autophagy, mitochondrial
dynamics, phagocytosis or inflammatory processes in the brain have previously been linked to Rab32. Here, we demonstrate
that Rab32 and Rab38, but no other GTPase tested, directly interact with LRRK2. GFP-Trap analyses confirmed the
interaction of Rab32 with the endogenous LRRK2. In yeast two-hybrid experiments we identified a predicted coiled-coil
motif containing region within the aminoterminus of LRRK2 as the possible interacting domain. Fluorescence microscopy
demonstrated a co-localization of Rab32 and LRRK2 at recycling endosomes and transport vesicles, while overexpression of
a constitutively active mutant of Rab32 led to an increased co-localization with Rab7/9 positive perinuclear late endosomes/
MVBs. Subcellular fractionation experiments supported the novel role of Rab32 in LRRK2 late endosomal transport and
sorting in the cell. Thus, Rab32 may regulate the physiological functions of LRRK2.
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Introduction
LRRK2 is a multi-domain protein of 280 kDa that contains
both, a GTPase domain (Ras of Complex =ROC) and a kinase
domain, regulating its cellular function [1,2,3]. Mutations
especially in these GTPase and kinase domains of LRRK2 are
the most common causes of heritable Parkinson’s disease (PD) and
also found in sporadic forms of PD [4]. The cellular function of
LRRK2 remains unknown, although there is evidence that these
mutations lead to cell death due to autophagic dysfunction and
mitochondrial damage [5,6,7].
LRRK2 has several known direct interacting partners, including
a couple of small GTPases from the Ras superfamily. The first
GTPase shown to directly interact with LRRK2 was Rab5B,
linked to the regulation of synaptic vesicle endocytosis [8]. Rac1
and CDC42 were also identified as LRRK2 interacting partners
[9,10]. In contrast to Rab5B, Rac1 is able to bind LRRK2 in a
nucleotide independent manner, but the activity status strongly
influences LRRK2 localization within the cell. Furthermore, the
constitutively active Rac1 mutant is able to rescue the neurite
retraction effect of the LRRK2 mutation G2019S in SH-SY5Y
cells [9]. In Drosophila it has been demonstrated that the
homologue to LRRK2 directly binds to Rab7 thus suggesting a
role in late endosomal/multivesicular body (MVB) or lysosomal
pathways [11]. The authors showed that the Drosophila homo-
logue of the most common PD mutant G2019S displays increased
co-localization with Rab7. In addition to Drosophila, human brain
and cultured human cells reveal LRRK2 localization to late
endosomal or lysosomal compartments [12,13,14]. Recent studies
show that Rab7L1 (or Rab29), the Rab protein most closely
related to Rab32 and Rab38, is a LRRK2 interacting protein as
well [15,16].
In this study, we demonstrate a novel mechanism of LRRK2
binding and transport, which involves the small GTPase Rab32.
Rab32 and its closest homologue Rab38 are known to organize
the trans-Golgi network (TGN) and thereby the transport of key
enzymes in melanogenesis like tyrosinase and Tyrp1 [17]. This
transport is mediated by the first known Rab32 and Rab38
effector Varp (also known as ANKRD27) [18]. This protein was
known as a guanine nucleotide exchange factor (GEF) for Rab21
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and involves the SNARE protein Vamp7 in Tyrp1 trafficking
[19,20].
Recently, novel Rab32 interacting partners were identified and
their role in melanogenesis and the generation of other types of
lysosome related organelles (LRO) was investigated [21]. LROs
are organelles sharing common features of lysosomes but with a
different specialized function. The group of LRO includes
melanosomes, lytic granules in T-cells, lamellar bodies in aveolar
endothelial cells or the dense granule in platelets [22,23]. It could
be demonstrated that Rab32 influences endosomal trafficking by
direct interaction with adapter protein complexes AP-1, AP-3 and
BLOC-2 (biogenesis of lysosome related organelles complex) [24].
The AP-3 complex was also shown to play a role in dense granule
biogenesis [25]. The protein complex BLOC-3, which is a GEF
for Rab32 and Rab38, also plays a role in LRO biogenesis.
Furthermore, one of the proteins in this complex is mutated in the
Hermansky-Pudlak syndrome [26].
However, the role of Rab32 in non-melanogenic cells is poorly
understood yet. It was shown, that Rab32 is a PKA anchoring
protein (AKAP) in melanogenic and non-melanogenic cells
[27,28]. In contrast to the finding that Rab32 is located to
mitochondria in WI-38 fibroblasts, HeLa and COS7 cells, no co-
localization of Rab32 with mitochondria could be detected in
melanocytes and some other cell lines by other groups [17,29].
Furthermore, there is evidence for Rab32 being involved in
autophagy and phagocytotic digestion of bacteria [29,30,31]. A
recent study implicates Rab32 in brain inflammation processes -
Rab32 and Rab20 mRNA levels were increased upon lipopoly-
saccharide (LPS) injection in mouse brain [32].
Here, we demonstrate that Rab32 and Rab38, but no other
GTPases tested, directly interact with LRRK2. In yeast two-
hybrid experiments we identify a predicted coiled-coil motif
containing region within the aminoterminus of LRRK2 as a
possible interacting domain. While microscopy analyses display a
co-localization of Rab32 and LRRK2 at pericentrosomal recycling
endosomes in addition to transport vesicles, overexpression of a
constitutively active mutant of Rab32 leads to an increased co-
localization at Rab7 and Rab9 positive perinuclear late endo-
somes/MVBs. Subcellular fractionation reveals that overexpres-
sion of constitutively active Rab32 decreases the amount of
LRRK2 in mitochondria and lysosome containing fractions.
Rab32-dependent localization of sub-cellular LRRK2 distribution
thereby demonstrates a role for Rab32 in LRRK2 sorting and
transport.
Material and Methods
Plasmids and cloning
Human Rab32 was amplified from pEGFP-Rab32 wt vector,
which was a kind gift from C. Wasmeier from M. Seabra’s group,
by PCR (primer forward: AGAATTCCATATGGCGGGCG-
GAGGAGCC; primer reverse: TACCTAGGTCAGCAACACT-
GGGATTTGTTC) and cloned into the plasmid pAS2-1 to
construct the yeast two-hybrid bait plasmid pAS-Rab32 wt [17].
The same primers were used to clone the constitutively active
GTP bound Rab32 Q85L mutant in the pAS2-1 vector, using
pDsRed-Monomer-Rab32 Q85L as template. This construct was
generated by site directed mutagenesis from pDsRed-Monomer-
Rab32 wt using the following primers: forward: GGGACA-
TCGCGGGGCTGGAGCGATTTGGCAAC; reverse: GTTG-
CCAAATCGCTCCAGCCCGATGTCCC. pDsRed-Monomer-
Rab32 wt was constructed similar to pAS-Rab32 (primer forward:
AAGAATTCTATGGCGGGCGGAGGAGC; primer reverse:
GTGGATCCTCAGCAACACTG). The yeast two-hybrid plas-
mids pAS-Rab38 wt and pAS-Rab38 Q69L were cloned by PCR
(primer forward: CAGAATTCCATATGCAGACACCTCA-
CAAG; primer reverse: CTGGATCCCCTAGGATTTGGCA-
CAGCC) amplifying murine Rab38 sequences from pEF-FLAG-
Rab38 wt and pEF-FLAG-Rab38 Q69L, which were a kind gift
from M. Fukuda, Tohoku University, Sendai, Japan [18]. Other
vectors used in this study were constructed by sub-cloning:
pACT2-LRRK2, pACT2-LRRK2-C, pACT2-LRRK2 1-266,
pACT2-LRRK2 265-552, pEGFP-Rab32 Q85L, pGEX42-
Rab32 wt, pECFP-Rab32 wt and -Q85L and pEGFP-Rab32
Q85L. All vectors constructed by PCR were verified by
sequencing. The pcDNA3-LRRK2-EGFP plasmid was described
before [3]. The plasmids pEYFP-Endo (RhoB) and pEGFP-
Rab5A were a kind gift from Theresia Stradals group, University
Muenster, Germany. pEGFP-Rab11B wt was a gift from Beate
Schlierf, University Erlangen, Germany [33].
Antibodies
Antibodies used in Western blotting were anti-human Rab32
and anti-LC3B antibodies from Sigma (St. Louis, MO, USA) and
used at a 1:1000 dilution. Mouse anti GAPDH was diluted 1:5000
(Invitrogen, Carlsbad, USA). The rat anti-LRRK2 (1E11)
hybridoma supernatant was produced by E. Kremmer, Helmholtz
Zentrum Mu¨nchen, Germany and the antibody was applied at a
1:50 dilution [34]. For the analysis of the GFP-Trap experiments
we used the MJFF2 rabbit anti LRRK2 antibody (Abcam,
Cambridge, UK) at a 1:2000 dilution and a mouse anti GFP
(JL-8, Clontech, Mountain View, USA) antibody at a dilution of
1:4000. HRP-coupled antibodies were used as secondary antibod-
ies for Western blotting. Anti-rabbit and anti-mouse secondary
antibodies were obtained from Cell Signaling Technology,
Danvers, MA, USA, and diluted 1:1000. Anti-rat IgG HRP was
from Jackson Immunoresearch, Newmarket, UK, and diluted
1:5000.
For immunofluorescent stainings anti-Rab7 and -Rab9 anti-
bodies (Cell Signaling Technology, Danvers, MA, USA) were used
at dilutions of 1:50 and 1:100, respectively. The mouse anti-Rab11
(clone47) antibody was obtained from Transduction Laboratories,
Lexington, USA). Mouse anti-b-tubulin hybridoma supernatant
(clone E7; Developmental Studies Hybridoma Bank, University of
Iowa, USA) was a kind gift from Sven Bogdan, University
Muenster, Germany. Both were used at 1:50 dilutions. Superna-
tants from mouse hybridoma to detect Rab6A (5B10) and Rab1B
(1E7) were described earlier [35,36,37]. Secondary antibodies
were coupled to Oyster594 (Luminartis GmbH, Muenster,
Germany), cy3 or Alexa488 (Jackson Immunoresearch, Newmar-
ket, UK). U. Schulze kindly provided us with the mouse anti-
LAMP2 antibody (clone H4B4; Developmental Studies Hybrid-
oma Bank, University of Iowa, USA), dilution was 1:250 in
secondary immunofluorescence and 1:5000 in Western blots.
Yeast two-hybrid
The human lung Matchmaker cDNA Library (Clontech,
Mountain View, CA, USA) was a kind gift from Stefan Ludwigs
Lab, UKM, Muenster, Germany. The reporter yeast strain Y190
(Clontech, Heidelberg, Germany) was co-transformed and colo-
nies were analyzed as described previously [38,39]. The reporter
strain Gold (Clontech, Heidelberg, Germany) was co-transformed
similar to the Y190 strain according to the manufacturer’s
instructions.
GST-pulldown and immunoprecipitation
GST-fusion proteins of Rab32 and GST alone as control were
expressed from pGEX-vectors in E. coli BL21 for three hours at
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room temperature after induction with 1 mM IPTG and lysed by
sonication in PBS pH 7.4 containing EDTA-free protease inhibitor
cocktail complete (Roche Diagnostics, Mannheim, Germany). After
addition of Triton X-100 (final concentration 1%) followed by
30 minutes incubation on ice, the lysates were cleared by
centrifugation. GST fusion proteins were purified using 10 ml bed
volume Glutathion Sepharose 4B (GE Healthcare Bioscience,
Freiburg, Germany). 5 mg of each GST fusion protein and GST as
negative control were used for each experiment. After loading the
beads and subsequent washing, NIH3T3 cell lysates were added
and incubated overnight at 4uC in an overhead shaker. Cell lysates
were made by adding pulldown buffer (10 mM Tris pH 7.4,
150 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, 0,2% Triton X-100,
complete EDTA free) to the three times PBS washed cell culture dish.
Subsequently, cells were harvested with a cell scraper and the lysate
was cleared by 1 hour centrifugation at 23,0006 g, 4uC. After
24 hours of incubation beads were washed in 200 ml pulldown
buffer three times and subjected to Western blot analysis.
Alternatively, Glutathione HiCap matrix (Qiagen, Hilden, Ger-
many) was used according to the manufacturer’s instructions.
For co-immunoprecipitation experiments confluently grown
cells on a 15 cm cell culture dish were harvested in co-IP buffer
(50 mM Tris pH 7.4, 150 mM NaCl, 1.5 mM MgCl, 4 mM
EDTA, 10% glycerol, 1% Triton X-100, complete EDTA-free).
After clearing the lysates by centrifugation, 1–2 mg of the antibody
was added. After 24 h incubation at 4uC in a rotator 10 ml of
Protein G Sepharose 4 Fast Flow (GE Healthcare Bioscience,
Freiburg, Germany) beads were added followed by incubation for
another hour. Thereafter, the beads were washed with 200 ml PBS
containing 0.2% Triton X-100 three times and the samples were
subjected to Western blot analysis.
For co-immunoprecipitation using the GFP-Trap kit (Chromo-
tek, Planegg-Martinsried, Germany) cells were harvested in a
modified GFP-Trap buffer (10 mM Tris pH 7.5, 150 mM NaCl,
0.5 mM EGTA, 0.5% NP40, 200 mM sodium orthovanadate,
complete EDTA free). The further procedure was according to the
manufacturers instructions.
Western blot
For Western blotting, cell lysates were mixed with 46 loading
dye (40% (v/v) glycerol, 8% (w/v) SDS, 32% (v/v) 1 M Tris/HCl
pH 6.8, 0.04% (v/v) bromophenol blue and 20% b-mercaptoeth-
anol) and incubated 5 min at 95uC. For LRRK2 samples
incubation time was reduced to 60–90 seconds. Samples were
subjected to SDS-PAGE [40]. Proteins were immobilized on
PVDF by semi dry Western blotting. The membrane was blocked
in 5% skimmed milk powder in PBS-T (0.1% Tween20 in PBS) for
1 hour at RT or over night at 4uC. Primary antibodies were
diluted in blocking solution and incubated for 60 min at RT or
over night at 4uC for the anti-LRRK2 antibodies. The secondary
antibodies (HRP conjugated) were diluted in blocking solution and
incubated for 30 min at RT. Subsequently, the membrane was
washed in PBS-T 66 for at least 5 min. Detection of proteins was
carried out on X-ray films using chemiluminescence.
Cell culture and transfection
NIH3T3 (ATTC number: CRL-1658) cells were cultured in
DMEM supplemented with 10% FBS and 4 mM glutamine. One
day prior to transfection, 56105 NIH3T3 cells were seeded in a
3.5 cm cell culture dish containing up to three 12 mm cover slides.
Co-transfection of either pDsRed-Monomer-Rab32 wt or -Q85L
and pcDNA3-LRRK2-EGFP was carried out using PolyFect
(Qiagen, Hilden, Germany) or Lipofectamine 2000 (Invitrogen,
Karlsruhe, Germany) according to the manufacturer’s instruc-
tions. All other transfections were performed by using TurboFect
(Thermo Scientific, Schwerte, Germany) according to the
manufacturer’s instructions.
The renal proximal tubule cell line IHKE-1 was a kind gift from
Thomas Weide, UKM, Muenster. Cells were grown in DMEM/
Ham’s F12 supplemented with 1% FBS, 15 mM HEPES (pH 7.2),
44 mM NaHCO3, 1 mM sodiumpyruvate, 4.5 mM L-glutamine,
36 ng/ml hydrocortisol, 10 ng/ml EGF, 5 mg/ml insulin, 5 mg/ml
transferrin and 5 ng/ml sodium selenite.
Like NIH3T3 cells, IHKE-1 cells were transfected with
TurboFect during passaging. 16105 cells were mixed with the
TurboFect-DNA dilution and plated in a 48 well cell culture dish.
The next day, cells were transferred to a 3.5 cm cell culture dish
containing 12 mm cover slides or two 3.5 cm dishes were
transferred to one 6 cm cell culture dish. After 24 hours cells
were either fixed or harvested for further experiments. To
generate IHKE-1 cell lines stably expressing GFP-Rab32 wt or
GFP-Rab32 Q85L, cells were transfected as described above and
then incubated with G418. After a few weeks colonies from
surviving cells were treated with trypsin, subjected to 48 well plates
and grown to confluence. The best of the resulting clones were
further cultivated and used for this study.
Secondary immunofluorescence
For secondary immunofluorescence cells were washed three times
with ice cold PBS and were fixed for 10 min on ice with 4% PFA in
250 mMHEPES, pH 7.4. An additional incubation step for 30 min
at room temperature (RT) followed. After washing with PBS three
times cells were incubated with 50 mM NH4Cl for 5 min at RT.
The cells were washed three times with PBS and permeabilized with
0.2% Triton X-100 in PBS for 5 min. Thereafter, cells were washed
three times with PBS containing 0.2% gelatine. Unspecific antibody
binding sites were blocked with 10% normal goat serum in PBS+
0.2% gelatine for 30 min followed by incubation with the primary
antibody in PBS+0.2% gelatine for 60 min. After that the cells were
washed three times with PBS+0.2% gelatine and subsequently
incubated with secondary antibody in PBS+0.2% gelatine for
20 min. Before embedding with Mowiol (Sigma Aldrich Chemie
GmbH, Taufkirchen, Germany) supplemented with DAPI and
DABCO, the cells were washed three times with PBS and three
times with ddH2O. The protocol was carried out in drops on
Parafilm beginning from the neutralization step. The samples were
analyzed with a Leitz Diaplan Fluorescence microscope (Leica,
Darmstadt, Germany) equipped with PL Fluotar 1006 - 1.32 NA
and PL Fluotar 506- 1.00 NA objectives or a Zeiss LSM5 live (Carl
Zeiss, Jena, Germany) with a Plan Apochromat 636 – 1.40 NA
objective.
Live cell imaging
For live cell imaging cells were grown in 8 well microscopic slides
(IBIDI, Martinsried, Germany) and transfected with Lipofectamine
2000 (Invitrogen, Karlsruhe, Germany) according to the manufac-
turer’s instructions. Cells were analyzed on an LSM5 live
microscope (Carl Zeiss, Jena, Germany). All images were taken in
the live mode as 8 bit images using a two-track recording setup.
Green and red channels were recorded in parallel for each time
point. Laser power and detector gain were adjusted as needed.
Microscopic imaging and determination of endosomal
size
Images were taken with a Leitz Diaplan Fluorescence micro-
scope equipped with PL Fluotar 1006 - 1.32 NA and PL Fluotar
506 - 1.00 NA objectives. Images were taken with an Olympus
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XM10 camera as 16 bit multipage.tif files, filters for green
(excitation: 450–490 nm, emission: 515–560 nm) and red (excita-
tion: 540–580 nm, emission: 607–682 nm) fluorescence guaran-
teed no bleed trough. Images were taken with constant exposure
time and analyzed with ImageJ [41]. For quantifying the size of
perinuclear late endosomes/MVBs the channel showing Rab7 was
blurred with a 2 px median filter followed by subsequent
background subtraction with a rolling ball radius of 20 px.
Thereafter, an adequate threshold was set manually and the image
was binarized. Data for analysis were generated by selecting the
perinuclear areas with the wand tool and measuring their sizes.
Subcellular fractionation
For subcellular fractionation IHKE-1 or IHKE-1 cells stably
transfected with either GFP-Rab32 wt or GFP-Rab32 Q85L were
grown on 15 cm diameter cell culture dishes to confluence. Then,
cells were washed 3 times with PBS, 4uC, and cell culture plates
were frozen at 270uC. To disrupt the cells we added 450 ml
fractionation buffer (250 mM sucrose, 20 mM HEPES (pH 7.4),
10 mM potassium chloride, 1.5 mM magnesium chloride, 1 mM
EDTA, 1 mM EGTA, 1 mM DTT, complete EDTA-free (Roche
Diagnostics, Mannheim, Germany)) and immediately scraped the
cells off. The lysate was collected to a tube and snap frozen in
liquid nitrogen and thawed 5 times. The resulting lysate was
pressed through a 27 Gauge needle with a syringe 20 times.
Appropriate disruption of the cells was assessed by light
microscopy. This whole cell lysate was separated into the different
fractions by subsequent centrifugation steps. First, centrifugation
at 7206 g for 5 minutes was for pelleting nuclei and bigger cell
debris. The resulting supernatant then was centrifuged at 20,0006
g for 20 minutes to sediment high density organelles like lysosomes
and mitochondria. The pellet was resuspended in 150 ml
fractionation buffer supplemented with 0.1% SDS. The resulting
lysate was used as crude mitochondria and lysosome containing
fraction (CLM). The supernatant containing light membrane
fragments and cytosolic proteins was used as C/M fraction.
Statistical analysis
Statistical analysis was performed by two-sided Student’s T-test
in Excel (Microsoft Corporation, Redmond, WA, USA) assuming
normal distribution. Differences with p-values less than 0.05 were
considered as significant.
Results
Yeast two-hybrid Interactions between LRRK2 and Rab32
Several studies have described the role of Rab32 in the context
of melanogenesis together with the most closely related Rab38
[17,24]. Both GTPases were described to act mostly in a
redundant fashion in melanogenic transport pathways. However,
Rab32 is not only expressed in melanin containing cells - several
groups have demonstrated by Northern as well as Western blot
analyses that lung tissue contains high levels of Rab32 mRNA and
protein [27,42,43]. To obtain further insight into the role of
Rab32 in non-melanogenic cells, we screened a human lung
library in a yeast two-hybrid assay using Rab32 wildtype (wt) as
bait. We screened up to 3.76107 clones and isolated four clones
which caused a strong activation of reporter genes in the presence
of Gal4BD-Rab32 wt fusion proteins. Sequence analyses identified
these clones as a DNA fragment encoding the amino acids 1–552
of human leucine rich repeat kinase 2 (LRRK2, Figure 1).
GST-Rab32 pulldowns and immunoprecipitation of
endogenous LRRK2
Although yeast two-hybrid experiments are suitable for detect-
ing new interacting partners of proteins, this method could identify
false positive results and therefore the interaction between Rab32
and LRRK2 required confirmation by independent methods.
Bacterially expressed GST-Rab32 wt and GST-Rab32 Q85L was
coupled to glutathione agarose beads and incubated with lysates
from NIH3T3 cells. These cells show highest endogenous LRRK2
expression of all cell lines we have tested. We were able to pull
down endogenous LRRK2 from NIH3T3 cell lysates using GST
fusion proteins of Rab32, but not with GST-Rab1A (not shown) or
GST alone (Figure 2A).
To further confirm the direct interaction of LRRK2 and
Rab32, co-immunoprecipitation experiments were performed. We
generated an IHKE-1 cell line stably expressing GFP-Rab32 wt
(IHKE GFP-Rab32 wt) and GFP-Rab32 Q85L (IHKE GFP-
Rab32 Q85L). This human renal cell line was made from
epithelial cells of the proximal tubule, which was demonstrated to
have high LRRK2 abundance [14,44,45]. IHKE-1 cells have the
advantage of relatively high LRRK2 expression and were easy to
transfect. Furthermore, Rab32 is abundant in kidney cells
[27,42,43]. Figure S1 shows the expression of endogenous
Rab32 in untransfected IHKE-1 cells and IHKE GFP-Rab32 wt
cell lines and GFP-Rab32 wt in the stably transfected cell line
(Figure S1). We pulled down endogenous LRRK2 using the 1E11
anti-LRRK2 antibody and probed for GFP-Rab32 wt by Western
blot analysis. We were able to detect GFP-Rab32 wt following
immuno-precipitation of LRRK2 (Figure 2B). In contrast, there
was a minor background in the absence of antibody (Figure 2B) or
a control antibody (data not shown). Unfortunately, we could not
detect endogenous Rab32 due to strong non-specific signals at the
molecular weight of the small GTPase.
Figure 1. LRRK2 constructs used in this study. ARM: armadillo repeats; ANK: ankyrin repeats; LRR: leucine rich repeats; ROC: Ras of complex;
COR: C-terminal of ROC; Kin: kinase domain; WD40: WD40 domain; c/c: coiled coil motif (aa 319–348).
doi:10.1371/journal.pone.0111632.g001
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Due to the lack of available antibodies suitable for the
immunoprecipitation of endogenous Rab32 we used the GFP-
Trap system as an alternative approach to confirm its interaction
with LRRK2. Recombinantly expressed GFP-Rab32 wt or GFP-
Rab32 Q85L allowed the co-precipitation of endogenous LRRK2
from IHKE-1 cell lines while no LRRK2 bound to a GFP-only
control (Figure 2C).
Rab32 specificity of the LRRK2 interaction
Generally, small GTPases are known to bind their effectors in a
highly specific manner. On the other hand, many interacting
partners are recognized by different Rabs at distinct or overlap-
ping binding sites. Notably, LRRK2 is known to bind several small
GTPases [8,9,10,15,16]. Thus, further investigations were needed
to test, whether the interaction is specific for Rab32. We used an
assortment of Rab cDNA molecules as bait constructs in yeast co-
transformation assays (Table 1). LRRK2-N induced cell growth
and a-galactosidase activity only when co-transformed with Rab32
or the closely related Rab38 plasmids. Other GTPases tested did
not interact, as evidenced by the inability to rescue growth and a-
galactosidase activity. Furthermore, we used co-transformation of
LRRK2-N with Tau as a negative control. Tau is a microtubule
binding protein forming neurofibrillary tangles in Alzheimer’s
disease and is also involved in Parkinson’s disease. However, there
are no apparent direct interactions between Tau and LRRK2
[46,47,48,49].
Mapping the Rab32 binding domain of LRRK2
To investigate which part of the LRRK2 protein acts as Rab32
binding domain, we generated several deletion mutants of LRRK2
and tested them in yeast two-hybrid co-transformation assays
(Figure 1, Table 2). A clear interaction signal was observed with
the LRRK2-N deletion mutant and the truncated LRRK2-N
clone, LRRK2 265–552 (Table 2). No interaction was observed
with the deletion mutants LRRK2 1–266 and LRRK2-C
indicating that the Rab32 binding domain lies within the amino
acids (aa) 267 to 552. The LRRK2 full length construct also did
not give a clear positive signal in these experiments, although we
could demonstrate the interaction of endogenous LRRK2 with
Rab32, as shown before (Figure 2). It is possible, that issues
regarding protein folding or posttranslational modifications in the
yeast cells lead to a false negative result in this experiment.
Very little is known about the function of the LRRK2
aminoterminus, which displays armadillo repeat structures. The
smallest Rab32 binding motif we found in our screen contained a
hypothetical coiled-coil motif spanning the amino acids 319 to
348. We found this motif by entering the first 552 residues of
LRRK2 to the coils algorithm (Figure S2) [50]. To elucidate,
whether this motif serves as the Rab32 interacting domain we
generated an additional LRRK2 deletion mutant that lacks this
hypothetical coiled-coil motif (LRRK2 aa 349–552: LRRK2Dcc,
Figure 1). Yeast co-transformation assays revealed that only the aa
265–552 fragment binds to Rab32, but not the one lacking the
region with the predicted coiled-coil motif (Table 3). Therefore,
Figure 2. Binding of endogenous LRRK2 by the small GTPase Rab32. (A) GST-Rab32 wt, GST-Rab32 Q85L or GST as control was applied to
glutathione agarose beads followed by incubation with NIH3T3 lysate overnight. Samples were analyzed by 6% SDS-PAGE and subsequent Western
blot analysis to detect LRRK2. n$3 independent experiments. (B) Lysates from IHKE-1 cells stably expressing GFP-Rab32 wt were incubated overnight
with an anti-LRRK2 antibody (1E11). IP control = no antibody was added. Co-precipitated GFP-Rab32 wt was detected using an anti-Rab32 antibody.
n = 3 independent experiments. (C) Lysates from IHKE-1 cells expressing GFP-Rab32 wt, GFP-Rab32 Q85L or GFP as control were subjected to
immunoprecipitation by the GFP-Trap kit. Co-precipitated endogenous LRRK2 was detected using an anti LRRK2 antibody. n = 2 independent
experiments.
doi:10.1371/journal.pone.0111632.g002
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we concluded that Rab32 is interacting with LRRK2 via this
coiled-coil motif.
Analysis of Rab32 and LRRK2 co-localization in various
intracellular compartments
Following verification and mapping of the Rab32-LRRK2
interactions, we analyzed their intracellular co-localization.
NIH3T3 cells were co-transfected with plasmids encoding
DsRed-Monomer-Rab32 wt and LRRK2-GFP. After 48 hours
cells were analyzed by live cell imaging. DsRed-Monomer-Rab32
and LRRK2-GFP partially co-localized in a structure at the center
of the cell (Figure 3A, Movie S1). Perinuclear as well as peripheral
punctate co-localization was also visible (Figure 3A, arrows).
In many cases the constitutively active mutant of a small Rab
GTPase looks like an exaggerated version of its wildtype and
thereby more explicit in phenotype. This has been observed, for
example, for Rab5 or Rab7, which form giant early endosomes or
perinuclear aggregates of late endosomes/MVBs, respectively
[51,52,53]. To investigate LRRK2-GFP co-localization with
constitutively active Rab32 we co-transfected plasmids encoding
DsRed-Monomer-Rab32 Q85L and LRRK2-GFP in NIH3T3
cells and compared them with DsRed-Monomer Rab32 wt co-
expressing cells. Surprisingly, the Q85L mutant looks rather
different from the wildtype (Figure 3B). It had a more diffuse
appearance, but most characteristic for the constitutively active
mutant are large perinuclear aggregates that occurred in over 90%
of all Rab32 Q85L expressing NIH3T3 cells we analyzed. We
observed significant co-localization of DsRed-Monomer-Rab32
Q85L and LRRK2-GFP in these perinuclear aggregates.
Live cell imaging revealed co-transport and sorting events of
LRRK2-GFP and Ds-Red-Monomer-Rab32 wt at vesicles
(Figure 3C, Movies S1 and S2). It was obvious that the co-
transport was not only directed to the center of the cell, but also
away from it (Movie S1). This indicates a presumable role for
Rab32 in LRRK2 sorting and transport in the cell.
To study the co-localization of Rab32 and LRRK2 in more
detail, we transfected cells with plasmids encoding either DsRed-
Monomer-Rab32 wt or LRRK2-GFP. Immunofluorescence
staining for b-tubulin showed that the area of co-localization
occurred pericentrosomal at the microtubule organizing center
(MtOC, Figure 3D). Both Rab32 and LRRK2 were also reported
to localize to the Golgi apparatus [3,14,15,29]. To examine,
whether the Golgi apparatus is the compartment of co-localiza-
tion, cells were either transfected with plasmids encoding DsRed-
Monomer-Rab32 wt or LRRK2-GFP and stained with an
antibody for the Golgi marker protein Rab6A (Figure 3E). We
could demonstrate co-localization of DsRed-Monomer-Rab32 wt
and Rab6A, but no co-localization of Rab6A and LRRK2-GFP
was detectable. Therefore we concluded that the compartment of
the interaction is not the Golgi apparatus. The perinuclear
aggregates that we observed in the constitutively activated mutant
co-localize neither with b-tubulin nor with Rab6A (data not
shown).
Table 1. Rab binding specificity of LRRK2-N.
bait plasmid prey plasmid QDO+X-a-gal+aureobasidin A
pAS2-1-Rab32 wt pACT2-LRRK2-N +
pAS2-1-Rab38 wt +
pAS2-1-Rab1B Q67L 2
pAS2-1-Rab1B Q67R 2
pAS2-1-Rab11A wt 2
pAS2-1-Rab5A wt 2
pAS2-1-Rab6A Q72L 2
pAS2-1-Rab6A Q72R 2
pAS2-1-Rab7DC 2
pAS2-1-tau 2
After co-transformation of the yeast strain Gold with the indicated plasmids, cells were grown on synthetic media lacking adenine and histidine supplemented with
125 ng/ml aureobasidin and 40 mg/ml X-a-gal. Cell growth and blue color indicated that the proteins interact.
2 no or reduced growth on selection media and no blue color, + colony growth on selection media and blue color. n$3 independent experiments.
doi:10.1371/journal.pone.0111632.t001
Table 2. Mapping of Rab32 binding domain within LRRK2.
bait vector prey vector QDO+X-a-gal+aureobasidin A
pAS2-1 Rab32 Q85L pACT2-LRRK2 2
pACT2-LRRK2-N +
pACT2-LRRK2 1-266 2
pACT2-LRRK2 265-552 +
pACT2-LRRK2-C 2
The yeast strain Gold was co-transformed with the indicated plasmids. Cells were grown on synthetic media lacking adenine and histidine. The medium was
supplemented with 125 ng/ml aureobasidin and 40 mg/ml X-a-gal. Cell growth and blue color indicated that the proteins interact.
2 no or reduced growth on selection media and no blue color, + colony growth on selection media and blue color. n$3 independent experiments.
doi:10.1371/journal.pone.0111632.t002
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Localization of Rab32 with endosomal marker proteins
Rab32 is known to organize lysosome related organelles (LRO)
and therefore to act within the endosomal system [17,24]. We
determined to which endosomal system Rab32 wt and constitu-
tively active Rab32 Q85L localize by co-transfecting the
corresponding constructs with plasmids encoding GFP-Rab11B
(recycling endosomes) or GFP-Rab5A (early endosomes). We
could not detect co-localization between DsRed-Monomer-Rab32
wt or -Q85L and GFP-Rab5A at early endosomes (Figure S3A).
This is in good agreement with the results from other groups, who
examined the role of Rab32 in the context of melanogenesis [25].
In contrast to Rab5A we observed substantial co-localization of
GFP-Rab11B with DsRed-Monomer-Rab32 wt at the pericen-
triolar region (Figure 4A) indicating the recycling endosome
nature of this structure. Compared to DsRed-Monomer-Rab32
wt, DsRed-Monomer-Rab32 Q85L displayed no co-localization
with GFP-Rab11B, especially not at the perinuclear aggregates.
For the detection of late endosomes/MVBs we transfected cells
with either GFP-Rab32 wt or -Q85L constructs. After 24 hours
cells were fixed and stained using an anti-Rab7 antibody
(Figure 4B). In contrast to the results obtained for GFP-Rab11B,
Rab7 strongly co-localized with the perinuclear aggregates of
DsRed-Monomer-Rab32 Q85L, but not with the pericentrosomal
GFP-Rab32 wt. In NIH3T3 cells expressing just LRRK2-GFP we
were able to detect a partial co-localization with Rab7 and Rab11
(Figure S4). Similar to the Rab7 experiment did co-staining of
GFP-Rab32 wt or -Q85L and Rab9. This small GTPase is known
for its function in mannose-6-phosphate receptor recycling from
late endosomes to the TGN [54]. We also observed only limited
co-localization of GFP-Rab32 wt and Rab9, but substantial co-
localization at the perinuclear aggregates of GFP-Rab32 Q85L
transfected cells (Figure S3B). Here, typically the brightest Rab9
intensity is next to the Rab32 signal, but lower intensity areas
matched with the aggregates. Although Rab32 fused to fluorescent
proteins (GFP, DsRed-Monomer) has a very ‘‘typical’’ phenotype
in NIH3T3 cells, we found similar distribution and co-localization
of Rab32 with the markers (as far as examined) in different cell
types like IHKE-1 (Figure S5 and S6A), HeLa or A549 cells (data
not shown). In conclusion, these data support a role of Rab32 in
transport processes from the Golgi apparatus via recycling
endosomes to late endosomes/MVBs or lysosomes.
Effects of wildtype and constitutively activated Rab32 on
late endosomes
It can easily be concluded from Figure 4B that constitutive
activation of Rab32 leads to an altered perinuclear accumulation
of Rab7 (Figure 4B). Therefore we measured the area of Rab7
staining that co-localized with GFP-Rab32 wt or -Q85L
(Figure 4C, arrows) and additionally the Rab7 that did not co-
localize with them in a small perinuclear region as indicated in
Figure 4C (Figure 4 C, arrowheads). Figure 4D shows that this
perinuclear Rab7 formed larger aggregates upon GFP-Rab32 wt
and especially -Q85L overexpression (Figure 4D). For perinuclear
Rab7 structures that co-localize with GFP-Rab32 wt we deter-
mined a median size of 0.77 mm2 and for GFP-Rab32 Q85L co-
localizing with Rab7 2.22 mm2 (Figure 4E). However, non co-
localizing Rab7 in the perinuclear region in untransfected control
cells had an area of just 0.33 mm2. Statistical analysis revealed that
these differences were highly significant (p,0.005). Rab7 positives
areas in the perinuclear region of transfected cells, where no co-
localization with Rab32 was observed, were about the size of the
untransfected control (GFP-Rab32 wt: 0.40 mm2; GFP-Rab32
Q85L: 0.34 mm2). This indicated a Rab32 activity-dependent
effect on the cellular localization of Rab7, which is a major
regulator of late endosome maturation and lysosome fusion [55].
To test, whether the changes in the degree of GFP-Rab32 wt or
-Q85L and Rab7 co-localization in NIH3T3 cells is a general
feature of Rab32 behavior, we repeated the co-localization
experiments with the Rab32 constructs and endogenous Rab7 in
a human cell line, the IHKE-1 cells. We cultivated IHKE-1 cells
stably transfected with GFP-Rab32 wt or -Q85L (IHKE GFP-
Rab32 wt or IHKE GFP-Rab32 Q85L) on cover slips, fixed them
and subsequently stained for Rab7 localization by secondary
immunofluorescence. We could demonstrate that Rab7 exhibits a
significantly higher overlap with GFP-Rab32 Q85L than GFP-
Rab32 wt does (Figure S6A). In contrast, LAMP2 shows co-
localization with both GFP-Rab32 wt and GFP-Rab32 Q85L, but
increased co-localization with the latter was not obvious (Figure
S6B). LAMP2 is a typical marker of lysosomes but also abundant
in late endosomes/MVBs and was shown to co-localize not only
with Rab7 but also with Rab32 wt and -Q85L before [29,56].
From our observations, we conclude that Rab32 targets its
interacting partners to late endosomes/MVBs. Activated Rab32
stimulates the formation of enlarged perinuclear late endosomes/
MVBs. Therefore it seems very interesting to investigate, whether
the novel Rab32 interacting protein LRRK2 changes its more
indistinct cellular distribution pattern upon activation of the
Rab32 GTPase and is targeted by activated Rab32 to late
endosomes/MVBs via recycling endosomes.
Rab32 mediates effects on the intracellular localization of
LRRK2
When we analyzed the localization of Rab32 in NIH3T3 cells,
we found considerable differences between the Rab32 wildtype
and the permanently GTP bound Rab32 Q85L mutant
(Figure 3A, B and Figure 4). In fact, Rab32 wt displays the major
degree of co-localization with LRRK2-GFP at pericentriolar
recycling endosomes and transport vesicles, while the constitutively
active mutant co-localizes with LRRK2-GFP in perinuclear
aggregates positive for the late endosomal marker Rab7. From
Table 3. Mapping of Rab32 binding motif within LRRK2 aminoterminus.
bait vector prey vector b-gal
pAS2-1 Rab32 Q85L pACT2-LRRK2 265–552 +
pACT2-LRRK2 Dcc 2
After co-transformation of the yeast strain Y190 with the indicated plasmids with and without the hypothetical coiled-coil motif, cells were grown on synthetic media
lacking histidine, supplemented with 30 mM 3 AT. Cell growth on these media and blue staining in subsequent b-gal-filter assays indicated direct interaction of the
proteins.
no growth on selection media or staining in ß-galactosidase filter assay, + growth on selection media and blue staining in in ß-galactosidase filter assay. n = 3
independent experiments.
doi:10.1371/journal.pone.0111632.t003
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this observation we hypothesized that Rab32 influences LRRK2
localization inside the cell.
To quantify the fluorescence microscopic analysis we tested the
localization of LRRK2-GFP expressed alone or co-expressed with
DsRed-Monomer-Rab32 wt or DsRed-Monomer Rab32 Q85L
for the abundance of different features: transport vesicles,
pericentriolar recycling endosomes and perinuclear aggregates
(Figure 5A). We found that in 50% of total cells expressing
LRRK2-GFP only small vesicles occurred. Co-expression of
DsRed-Monomer-Rab32 wt with LRRK2-GFP increased this
value to 100% of total cells recorded (Figure 5B). In contrast, upon
DsRed-Monomer-Rab32 Q85L co-expression with LRRK2-GFP,
only a few cells with LRRK2-GFP positive vesicles remained. A
similar result was observed for pericentriolar endosomes (Fig-
ure 5C). LRRK2-GFP alone displays this typical feature less often
(59%) than DsRed-Monomer-Rab32 wt co-expressing cells (92%).
Perinuclear aggregates were characteristic for the constitutively
active mutant Rab32 Q85L. Looking at LRRK2-GFP this feature
occurred in 90% of all DsRed-Monomer-Rab32 Q85L co-
expressing cells (Figure 5D). While co-transfected with DsRed-
Figure 3. Co-localization analysis of LRRK2-GFP and DsRed-Monomer-Rab32. (A) NIH3T3 cells were co-transfected with plasmids encoding
DsRed-Monomer-Rab32 wt and LRRK2-GFP. Living cells were imaged using a Zeiss LSM5 live microscope. The image shows a still frame from Movie
S1. Scale bar = 10 mm. (B) NIH3T3 cells were co-transfected with plasmids encoding DsRed-Monomer-Rab32 Q85L and LRRK2-GFP. After 48 hours the
cells were fixed in 4% PFA and subsequently analyzed with a laser scanning microscope. Scale bar = 10 mm. (C) Co-transport and sorting of LRRK2-GFP
by DsRed-Monomer-Rab32 wt. Image series are a detail view from Movie S2. Both channels were recorded simultaneously every second. Scale
bar = 2 mm. (D and E) NIH3T3 cells expressing either DsRed-Monomer-Rab32 wt or LRRK2-GFP were fixed and subsequently subjected to
immunofluorescence labeling of b-tubulin (D) or the Golgi marker Rab6A (E). Scale bar = 10 mm.
doi:10.1371/journal.pone.0111632.g003
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Monomer-Rab32 wt or expressing LRRK2-GFP alone, perinu-
clear aggregates seemed to be smaller in size and occurred much
more infrequently (see also Figure 4C and D). These results show
that co-expression of activated or wt Rab32 impacts the cellular
localization of LRRK2-GFP in an activity-dependent manner.
To verify these data, we performed subcellular fractionation
experiments. IHKE-1 cells that either stably expressed GFP-
Rab32 wt or GFP-Rab32 Q85L and untransfected IHKE-1 cells
as a control were grown on 15 cm diameter cell culture dishes,
lysed and crude fractions were prepared. We prepared a fraction
which contains lysosomes and mitochondria (CLM=crude
lysosome and mitochondria) and a second fraction which contains
the cytosol and light membranes like microsomes and endosomes
[57]. LAMP2, GAPDH and Rab1B expression detected by
Western blotting confirmed that the fractions were relatively pure
(Figure 6A and data not shown). We were able to detect GFP-
Rab32 wt and GFP-Rab32 Q85L in both fractions, but to a
different extent225.7%67.7% of GFP-Rab32 wt signal is present
in the C/M fraction, while 74.3%67.7% is in the CLM fraction.
By comparison, GFP-Rab32 Q85L is significantly higher in the
C/M fraction: 55.1%67.4% was found in the C/M fraction, but
just 44.9%67.4% in the CLM fraction.
The subcellular distribution of LRRK2 follows the one of
Rab32: The C/M fractions displayed an increase in LRRK2
protein content comparing control IHKE-1 cells with GFP-Rab32
wt or GFP-Rab32 Q85L expressing cells and a decrease of
LRRK2 protein content in the CLM fraction, respectively
(Figure 6A). Quantification of the Western blot signals confirms
that in the control cells 39.1%67.6% of the LRRK2 protein was
present in the C/M fraction (60.9%67.6% in the CLM fraction),
for IHKE GFP-Rab32 wt 54.2%63.4% (45.8%63.4%) and for
IHKE GFP-Rab32 Q85L 75.9%65.7% (24.1%65.7%, Fig-
ure 6B).
A distinction between late endosomes/MVB and lysosomes
upon co-localization analyses of Rab32 Q85L positive perinuclear
aggregates and Rab7 in NIH3T3 cells is not possible. This is
because Rab7 is found on both types of organelles [55]. The
reduction of LRRK2 in the CLM fraction in IHKE GFP-Rab32
Q85L cells together with the observation of increased co-
localization of the constitutively active GFP-Rab32 Q85L with
Figure 4. Co-localization analysis of Rab32 wt and the constitutively active mutant Rab32 Q85L with different endosomal markers.
(A) NIH3T3 cells were co-transfected with plasmids encoding the recycling endosome marker GFP-Rab11B and DsRed-Monomer-Rab32 wt or DsRed-
Monomer-Rab32 Q85L, fixed and analyzed by fluorescence microscopy. Scale bar = 10 mm. (B) Cells were transfected with plasmids encoding for GFP-
Rab32 wt or GFP-Rab32 Q85L followed by fixation and subsequent immunofluorescence staining of Rab7. Scale bar = 10 mm. (C–E) NIH3T3 cells
expressing either GFP-Rab32 wt or GFP-Rab32 Q85L were fixed and stained for Rab7. (C) Microscopic analysis of GFP-Rab32 Q85L that co-localized
with endogenous Rab7 (arrows) in the perinuclear area. Non co-localizing Rab7 was indicated by arrowheads. The perinuclear area was defined by
the red (outlines nucleus) and the yellow line (outer border for perinuclear area). The image illustrates the cellular area used for the following analysis.
(D) Rab7 perinuclear aggregates co-localizing with GFP-Rab32 wt or GFP-Rab32 Q85L and non co-localizing ones. ctrl. = control (untransfected IHKE-1
cells) (E) Quantification of perinuclear Rab7-positive structures. ctrl. (control): perinuclear Rab7 in untransfected cells; wt/Q85L: perinuclear Rab7 co-
localizing with GFP-Rab32 constructs. control/Rab32 wt/Rab32 Q85L: n = 1660/18/167 structures in 67/18/60 cells, 1/1/3 independent experiments.
Statistical significance was tested by a Student’s T-test: pcontrol-wt = 0.02; pcontrol-Q85L,0.005; pwt-Q85L = 0.02. Scale bar = 10 mm.
doi:10.1371/journal.pone.0111632.g004
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Rab7 (but not LAMP2) precludes the possibility that LRRK2 is
sorted to lysosomes by Rab32. This is supported by the
observation that incubation of neither untransfected IHKE-1 cells
nor cells stably transfected with GFP-Rab32 wt with the lysosomal
degradation inhibitor Bafilomycin A led to increased LRRK2
levels compared to control cells (Figure S7). Proteins destined for
degradation under normal conditions can accumulate upon
inhibition of lysosomal degradation via inhibitors. Taken together,
these data suggest that the perinuclear aggregates originate from
late endosomal structures, and are not associated with lysosomes.
Discussion
We identified the aminoterminal LRRK2 fragment as a novel
Rab32 interacting partner in a yeast two-hybrid screen. Co-
immunoprecipitation of GFP-Rab32 or endogenous LRRK2 from
IHKE-1 cells confirmed the interaction. Furthermore, pulldown of
Figure 6. Subcellular fractionation analysis of endogenous LRRK2 in IHKE-1 cells overexpressing GFP-Rab32 wt or GFP-Rab32
Q85L. (A) IHKE-1 cells either untransfected (-) or stably overexpressing GFP-Rab32 wt or GFP-Rab32 Q85L were mechanically disrupted and
fractionated by differential centrifugation. Fractions received either contained lysosomes and mitochondria (CLM) or cytosol and light membranes (C/
M). Western blot analysis to detect the lysosomal marker LAMP2, GAPDH, Rab32 and LRRK2 were performed with the fractions derived from the
different IHKE-1 cells. (B) Quantification of Western blot signal intensities using the gel analyzer functionality of ImageJ. The signal intensity for both
the C/M and the CLM fraction was added and set to 100%. The graph shows the % of GFP-Rab32 and endogenous LRRK2 in the C/M fraction of the
different cell lines. n = 6 independent experiments. Error bars represent S.E.M.; n.s. = not significant; * = p,0.05; ** = p,0.01.
doi:10.1371/journal.pone.0111632.g006
Figure 5. LRRK2-GFP subcellular localization in DsRed-Monomer-Rab32 wt and DsRed-Monomer-Rab32 Q85L overexpressing
NIH3T3 cells. (A) Graphical representation of the most common subcellular features of LRRK2-GFP in DsRed-Monomer-Rab32 wt or DsRed-
Monomer-Rab32 Q85L expressing cells. 1: pericentriolar endosome; 2: transport vesicles; 3: perinuclear aggregates. (B–D) Microscopic analysis of
NIH3T3 cells co-transfected with plasmids encoding DsRed-Monomer-Rab32 wt or DsRed-Monomer-Rab32 Q85L and LRRK2-GFP. In every cell the
LRRK2-GFP channel was analyzed for the occurrence of the features transport vesicles, pericentriolar endosomes and perinuclear aggregates. (-)
LRRK2-GFP alone: n = 71 cells from 5 independent experiments; LRRK2-GFP and DsRed-Monomer-Rab32 wildtype: n = 15 cells from 3 independent
experiments, LRRK2-GFP and DsRed-Monomer-Rab32 Q85L: n = 21 cells from 5 independent experiments.
doi:10.1371/journal.pone.0111632.g005
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endogenous LRRK2 from NIH3T3 cells using recombinant GST-
Rab32 supported the interaction (Figure 2).
When checking for binding specificity, we found that the
LRRK2 interaction is Rab32 and Rab38 specific. Noteworthy,
other GTPases tested did not interact with the aminoterminal
fragment of LRRK2 that we identified in the yeast two-hybrid
screen. Yet another small GTPase, the Rab29 protein (also known
as Rab7L1), was recently identified as a new LRRK2 interacting
partner [15,16]. Evolutionarily, Rab29 is most closely related to
Rab32 and Rab38. These three GTPases actually belong to a
subfamily, based on subtle differences in the generally conserved
G-domain, relative to other Rab proteins [42,58].
In this study we showed that Rab32 binds to the aminoterminal
region of LRRK2 whose function is largely unknown so far. Only
two domains have previously been described in this region: an
ankyrin repeats domain spanning the amino acids 676–902 of
human LRRK2, and an armadillo repeats domain from amino
acid 49 to 657 [59]. Although the Rab32 and Rab38 interacting
partner Varp (or ANKRD27) was shown to bind the GTPases in
its ankyrin repeats domain, the Rab32 interacting domain of
LRRK2 was located within the armadillo repeats [18]. Because
armadillo repeats are known to interact with GTPases, it was
speculated, that GTPases are a possible target also for the LRRK2
armadillo repeat domain [60]. In our experiments we could
demonstrate that a putative coiled-coil motif within the first 552 aa
of human LRRK2 is mandatory for Rab32 binding. Homology
modeling of the LRRK2 armadillo repeats domain revealed an
extended loop that contains the PD mutation E334K at the
position of the putative coiled-coil motif [59,60]. This loop
between armadillo repeat 6 and 7 is part of the Rab32 binding
region we identified in this work. Whether this mutation is
interfering with the binding capacity to Rab32 remains to be
elucidated.
Besides the analysis of Rab32 binding to LRRK2, we could
demonstrate the co-localization of LRRK2 and wildtype Rab32 at
transport vesicles and recycling endosomes and for LRRK2 and
the constitutively active Rab32 mutant at late endosomes/MVB.
In live cell imaging experiments we observed several sorting
events, thus demonstrating co-transport of Rab32 and LRRK2. It
has previously been shown that LRRK2 co-localizes with
endosome markers such as Rab7 and Rab5B, or the endosomal
transport marker c-adaptin [6,8,11,12,13,14]. The latter was part
of the AP-1 adapter protein complex, which was recently
demonstrated to directly interact with Rab32 [24]. This interac-
tion plays a role in Rab32 mediated endosomal transport of LRO
containing cells like melanocytes or platelets [17,24,25]. Even
more, the AP-1 complex subunit b-1 was found in a GST-
pulldown based screen to directly interact with LRRK2 [61].
Together with our own observations these findings suggest a role
for Rab32 in LRRK2 late endosomal transport and sorting.
Constitutively activated Rab32 showed increased co-localiza-
tion with the late endosome/MVB marker Rab7 in IHKE-1 cells
or Rab7 positive perinuclear aggregates in NIH3T3 cells. We
demonstrated that overexpression of constitutively active Rab32
led to an increased size of perinuclear aggregates, an observation
also made by another group upon LRRK2 G2019S overexpres-
sion [11]. Here, the authors came to the conclusion, that LRRK2
influences the Rab7 dependent lysosome positioning in the cell.
Several groups have demonstrated that small GTPases seemed to
be responsible for LRRK2 localization changes in cells [8,9,15].
Our data also support a role for Rab32 in LRRK2 intracellular
localization. We could not only demonstrate that Rab32 Q85L
overexpression led to the translocation of LRRK2-GFP to the
Rab7 positive perinuclear aggregates, but also that Rab32 Q85L
induced the formation of these structures. The precise mechanism
remains to be elucidated in future work.
Activated Rab32 did not simply seem to guide LRRK2 to
lysosomes. We treated GFP-Rab32 stably expressing IHKE-1 cells
with the lysosomal degradation inhibitor bafilomycin A. If Rab32
increases LRRK2 lysosomal degradation in GFP-Rab32 overex-
pressing cells, we would expect accumulation of LRRK2 upon
Bafilomycin A treatment, but this was not the case. Furthermore,
subcellular fractionation revealed that GFP-Rab32 overexpression
and expression of constitutively active Rab32 removed LRRK2
from the lysosomes and mitochondria containing fraction. This
indicates that the Rab7 positive aggregates of co-localized LRRK2
with Rab32 Q85L represent enlarged late endosomes or MVBs.
In addition to the function of Rab32 in cells containing LROs, a
role for Rab32 in regulating mitochondria has been identified
[17,29]. Rab32 was found at the mitochondria-ER interface,
where it was demonstrated to act as PKA anchoring protein
[27,62]. PKA in turn was shown to phosphorylate LRRK2 which
is then mediating cytotoxic effects that were assumed to play a role
in the pathogenesis of PD [63,64]. LRRK2 is involved in
mitochondrial dysfunction, which is discussed as a cause of
Parkinson’s disease [65]. Our fractionation experiments showed
that Rab32 recruited LRRK2 away from the lysosome and
mitochondria containing fraction in IHKE-1 cells upon overex-
pressing wildtype or constitutively active Rab32. Although we
focused on the role of Rab32 in LRRK2 LE/lysosomal
localization it cannot be excluded, that activated or overexpressed
GFP-Rab32 targets LRRK2 away from mitochondria and
mediates its transport to late endosomes/MVB.
Taken together our results describe Rab32 as a novel LRRK2
interacting protein controlling its late endosomal trafficking,
implying a novel role in regulation of the LRRK2 protein. A
distinct role of the Rab32 GTPase in PD remains still illusive. It
was shown, that Rab32 is present in brain, but the expression is
very low under normal conditions [43,58]. It has recently been
demonstrated, that Rab32 mRNA levels increase in mouse brains
after stimulation with LPS [32]. Whether there is an elevated
Rab32 expression under pathophysiological conditions, like PD,
remains to be elucidated. For the small GTPases Rab5B, Rab7
and RAB7L1 (Rab29), a regulatory role on LRRK2 in PD has
recently been described [8,15,16]. Furthermore, there is evidence,
that LRRK2 itself plays a role in late endocytic transport
pathways. It could be demonstrated, that the PD mutation
LRRK2 G2019S decreased the transport of EGF in a Rab7
mediated manner [66]. Similar to the Rab32 regulation of late
endosomal transport processes, the LRRK2 interacting GTPase
Rab7L1 regulates late endosomal transport of LRRK2, as well
[15]. Therefore, a role for Rab32 in processes underlying the
pathophysiology of PD is definitely possible making it to a
promising target for further functional studies.
Supporting Information
Figure S1 Expression of endogenous Rab32 and GFP-
Rab32 wt in control IHKE-1 and stably transfected
IHKE-1 (IHKE GFP-Rab32 wt) cells. Equal amounts of cell
lysate from IHKE-1 and IHKE GFP-Rab32 wt were subjected to
SDS-PAGE followed by Western blotting. Rab32 was detected
with an anti-Rab32 antibody.
(TIF)
Figure S2 Coiled-coil motif prediction within LRRK2
residues 1–552. The first 552 amino acids of LRRK2 were
entered to the coils algorithm that calculates the probability of
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coiled-coil motifs. The image detects a high probability of such a
structure between the amino acids 319–348.
(TIF)
Figure S3 Co-localization analysis of DsRed-Monomer-
Rab32 wt and DsRed-Monomer-Rab32 Q85L with GFP-
Rab5A and GFP-Rab32 wt and GFP-Rab32 Q85L with
endogenous Rab9. (A) For Rab5 co-localization analysis
NIH3T3 cells were co-transfected with plasmids encoding for
DsRed-Monomer-Rab32 wt or DsRed-Monomer-Rab32 Q85L
and the early endosomal marker protein GFP-Rab5A. Cells were
fixed in 4% PFA and subjected to microscopic analyzes. Scale
bar = 10 mm. (B) For Rab9 co-localization analysis NIH3T3 cells
were transfected with the indicated GFP-Rab32 wt or GFP-Rab32
Q85L expression plasmids. 24 hours after transfection cells were
fixed and subjected to secondary immunofluorescence staining of
Rab9. Scale bar = 10 mm.
(TIF)
Figure S4 Co-localization analysis of LRRK2-GFP with
Rab7 and Rab11. For co-localization analysis NIH3T3 cells
were transfected with plasmids encoding for LRRK2-GFP and
immunostained for Rab7 or Rab11 localization, respectively. Cells
were fixed in 4% PFA and subjected to microscopic analyzes.
Scale bar = 10 mm.
(TIF)
Figure S5 Golgi and endosomal co-localization of GFP-
Rab32 wt. IHKE-1 cells were transiently transfected with
pEGFP-Rab32 wt. After 24 hours cells were fixed and immuno-
stained for the indicated proteins. Scale bar = 10 mm.
(TIF)
Figure S6 Analysis of GFP-Rab32 wt and GFP-Rab32
Q85L co-localization with Rab7 and LAMP2 in IHKE-1
cells. (A) IHKE GFP-Rab32 wt and IHKE GFP-Rab32 Q85L
cells were grown on glass cover slips, fixed and stained for Rab7 by
secondary immunofluorescence. Scale bar = 10 mm. (B) IHKE
GFP-Rab32 wt and IHKE GFP-Rab32 Q85L cells were grown on
glass cover slips, fixed and stained for LAMP2 by secondary
immunofluorescence. Scale bar = 10 mm.
(TIF)
Figure S7 LRRK2 expression in untransfected (IHKE-1)
and IHKE GFP-Rab32 wt cells upon Bafilomycin A
treatment. Western blots of endogenous LRRK2 and LC3B of
IHKE-1 and stably GFP-Rab32 wt expressing IHKE-1 cells. Cells
were grown for 24 hours. After incubation with 100 nM
Bafilomycin A for another 24 hours, cells were lysed and the
proteins separated by SDS-PAGE followed by subsequent Western
blot analysis. n = 3 independent experiments.
(TIF)
Movie S1 Live cell imaging of DsRed-Monomer-Rab32
wt and LRRK2-GFP. NIH3T3 cells were grown in live cell
microscopy chambers for 24 hours. Then, cells were transfected
with plasmids encoding DsRed-Monomer-Rab32 wt and LRRK2-
GFP. After 48 hours of incubation living cells were imaged using a
Zeiss LSM5 live microscope. Images were captured in live mode
every second, both channels simultaneously.
(MP4)
Movie S2 Live cell imaging of DsRed-Monomer-Rab32
wt and LRRK2-GFP. NIH3T3 cells were grown in live cell
microscopy chambers for 24 hours. Then, cells were transfected
with plasmids encoding DsRed-Monomer-Rab32 wt and LRRK2-
GFP. After 48 hours of incubation living cells were imaged using a
Zeiss LSM5 live microscope. Images were captured in live mode
every second, both channels simultaneously.
(MP4)
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